Opiant Expands Partnership with Sanofi Acute Cannabinoid Overdose (ACO), Business, Cannabinoids, Contract Development Manufacturing Organization (CDMO), Emergency Rooms, Partnerships Opiant Pharmaceuticals Inc. announced an agreement with Sanofi to manufacture Opiant’s investigational agent OPNTOO4 (drinabant) for the treatment of Acute Cannabinoid Overdose. Read more July 23, 2019/by GlobeNewswire https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 GlobeNewswire https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png GlobeNewswire2019-07-23 08:00:242019-07-23 18:04:34Opiant Expands Partnership with Sanofi
